Endobronchial Ultrasound Biopsy Market Size, Share, and Growth Analysis, By Product (EBUS Scopes, EBUS Needles), By Procedure (EBUS-Transbronchial Needle Aspiration (EBUS-TBNA), EBUS-Guided Biopsy), By End use, By Region - Industry Forecast 2026-2033

Global Endobronchial Ultrasound Biopsy Market size was valued at USD 744.79 Million in 2024 and is poised to grow from USD 781.28 Million in 2025 to USD 1145.55 Million by 2033, growing at a CAGR of 4.9% during the forecast period (2026-2033).

The global endobronchial ultrasound biopsy (EBUS) market is experiencing significant growth, fueled by a heightened emphasis on early lung cancer diagnosis and a preference for minimally invasive procedures. Technological advancements in EBUS equipment, including scopes and ultrasound processors, enhance procedural accuracy, increasing demand among hospitals and specialized clinics. An aging population and rising incidence of respiratory diseases such as COPD and tuberculosis further drive the need for EBUS diagnostics, particularly in advanced economies and emerging markets like Japan, China, and India. However, high equipment costs and inconsistent reimbursement policies in low- and middle-income countries present challenges to widespread EBUS adoption. Despite these hurdles, the growing interest from healthcare providers and the establishment of effective clinical pathways are encouraging further market development.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Endobronchial Ultrasound Biopsy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Endobronchial Ultrasound Biopsy Market Segments Analysis

Global Endobronchial Ultrasound Biopsy Market is segmented by Product, Procedure, End use and region. Based on Product, the market is segmented into EBUS Scopes, EBUS Needles, Ultrasound Processors & Imaging Systems and Accessories. Based on Procedure, the market is segmented into EBUS-Transbronchial Needle Aspiration (EBUS-TBNA) and EBUS-Guided Biopsy. Based on End use, the market is segmented into Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Endobronchial Ultrasound Biopsy Market

The global Endobronchial Ultrasound (EBUS) Biopsy market is primarily driven by the rising prevalence of lung cancer and various pulmonary diseases. EBUS procedures offer a minimally invasive method for accessing mediastinal and hilar lymph nodes, essential for the diagnosis and staging of lung malignancies. As health awareness grows, many nations are recognizing the critical importance of early detection, leading to increased implementation of lung cancer screening programs across healthcare systems in both developed and emerging economies. This shift in healthcare practices is creating a demand for alternatives to traditional surgical pathology and flexible bronchoscopy, elevating the significance of EBUS-TBNA and resulting in heightened clinical demand, which in turn pressures hospitals for immediate procurement and enhances procedural volumes within respiratory and oncology practices.

Restraints in the Global Endobronchial Ultrasound Biopsy Market

The Global Endobronchial Ultrasound Biopsy market faces significant challenges due to the high costs associated with acquiring, maintaining, and implementing EBUS systems. This remains a major hurdle, particularly for smaller healthcare facilities and institutions in low- and middle-income countries. The financial burden imposed by capital equipment, disposable biopsy needles, and ongoing servicing costs often restricts adoption to larger tertiary hospitals or academic centers. Consequently, this limits market regulation and restricts patient access to advanced diagnostic capabilities in more varied healthcare settings. Additionally, the absence of effective procurement options or volume-based subsidies exacerbates the difficulty for healthcare administrators aiming to implement EBUS technology on a broader scale.

Market Trends of the Global Endobronchial Ultrasound Biopsy Market

The Global Endobronchial Ultrasound Biopsy (EBUS) market is witnessing a transformative trend driven by the integration of artificial intelligence (AI) in imaging and navigation. AI-enhanced algorithms are streamlining the biopsy process by improving the accuracy of lesion identification and lymph node evaluation, ultimately minimizing operator variability. This incorporation of advanced technology not only boosts diagnostic precision, particularly for early-stage lung cancer, but also enhances overall procedural efficiency and outcome quality for healthcare providers. As a result, institutions employing AI-equipped EBUS systems are experiencing reduced procedure times and better patient prognoses, signaling a significant leap forward in respiratory care innovation.